• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯基取代呋喃和噁唑羧酸衍生物的合成及生物活性作为潜在的 PDE4 抑制剂。

Synthesis and bioactivity of phenyl substituted furan and oxazole carboxylic acid derivatives as potential PDE4 inhibitors.

机构信息

State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources, Integrative Microbiology Research Centre, Guangdong Province Key Laboratory of Microbial Signals and Disease Control, South China Agricultural University, Guangzhou, 510642, China.

Guangdong Laboratory for Lingnan Modern Agriculture, Guangzhou, 510642, China; Department of Applied Chemistry, College of Materials and Energy, South China Agricultural University, Guangzhou 510642, China.

出版信息

Eur J Med Chem. 2020 Dec 1;207:112795. doi: 10.1016/j.ejmech.2020.112795. Epub 2020 Sep 4.

DOI:10.1016/j.ejmech.2020.112795
PMID:33002845
Abstract

In this present study, a series of 5-phenyl-2-furan and 4-phenyl-2-oxazole derivatives were designed and synthesized as phosphodiesterase type 4 (PDE4) inhibitors. In vitro results showed that the synthesized compounds exhibited considerable inhibitory activity against PDE4B and blockade of LPS-induced TNF-α release. Among the designed compounds, Compound 5j exhibited lower IC value (1.4 μM) against PDE4 than parent rolipram (2.0 μM) in in vitro enzyme assay, which also displayed good in vivo activity in animal models of asthma/COPD and sepsis induced by LPS. Docking results suggested that introduction of methoxy group at para-position of phenyl ring, demonstrated good interaction with metal binding pocket domain of PDE4B, which was helpful to enhance inhibitory activity.

摘要

在本研究中,设计并合成了一系列 5-苯基-2-呋喃和 4-苯基-2-恶唑衍生物,作为磷酸二酯酶 4 型(PDE4)抑制剂。体外实验结果表明,合成的化合物对 PDE4B 具有较强的抑制活性,并能阻断 LPS 诱导的 TNF-α释放。在所设计的化合物中,化合物 5j 在体外酶测定中对 PDE4 的抑制活性(IC50 值为 1.4 μM)优于母体罗利普兰(IC50 值为 2.0 μM),并且在 LPS 诱导的哮喘/COPD 动物模型和脓毒症动物模型中也显示出良好的体内活性。对接结果表明,苯环对位引入甲氧基,与 PDE4B 的金属结合口袋域表现出良好的相互作用,有助于增强抑制活性。

相似文献

1
Synthesis and bioactivity of phenyl substituted furan and oxazole carboxylic acid derivatives as potential PDE4 inhibitors.苯基取代呋喃和噁唑羧酸衍生物的合成及生物活性作为潜在的 PDE4 抑制剂。
Eur J Med Chem. 2020 Dec 1;207:112795. doi: 10.1016/j.ejmech.2020.112795. Epub 2020 Sep 4.
2
Design, synthesis and biological evaluation of 2,4-disubstituted oxazole derivatives as potential PDE4 inhibitors.作为潜在磷酸二酯酶4(PDE4)抑制剂的2,4-二取代恶唑衍生物的设计、合成及生物学评价
Bioorg Med Chem. 2017 Mar 15;25(6):1852-1859. doi: 10.1016/j.bmc.2017.01.047. Epub 2017 Feb 3.
3
Synthesis and bioactivity of 3,5-dimethylpyrazole derivatives as potential PDE4 inhibitors.作为潜在磷酸二酯酶4(PDE4)抑制剂的3,5-二甲基吡唑衍生物的合成及生物活性
Bioorg Med Chem Lett. 2018 Oct 15;28(19):3276-3280. doi: 10.1016/j.bmcl.2018.03.031. Epub 2018 Mar 13.
4
Rational design of conformationally constrained oxazolidinone-fused 1,2,3,4-tetrahydroisoquinoline derivatives as potential PDE4 inhibitors.作为潜在磷酸二酯酶4(PDE4)抑制剂的构象受限的恶唑烷酮稠合1,2,3,4-四氢异喹啉衍生物的合理设计。
Bioorg Med Chem. 2017 Oct 15;25(20):5709-5717. doi: 10.1016/j.bmc.2017.08.045. Epub 2017 Sep 1.
5
Synthesis and bioactivity of pyrazole and triazole derivatives as potential PDE4 inhibitors.作为潜在磷酸二酯酶4(PDE4)抑制剂的吡唑和三唑衍生物的合成及生物活性
Bioorg Med Chem Lett. 2016 Aug 1;26(15):3632-5. doi: 10.1016/j.bmcl.2016.06.002. Epub 2016 Jun 2.
6
Structure-based design and structure-activity relationships of 1,2,3,4-tetrahydroisoquinoline derivatives as potential PDE4 inhibitors.作为潜在磷酸二酯酶4(PDE4)抑制剂的1,2,3,4-四氢异喹啉衍生物的基于结构的设计及构效关系
Bioorg Med Chem Lett. 2018 Apr 15;28(7):1188-1193. doi: 10.1016/j.bmcl.2018.02.056. Epub 2018 Mar 6.
7
Design, synthesis and biological evaluation of novel tetrahydroisoquinoline derivatives as potential PDE4 inhibitors.新型四氢异喹啉衍生物作为潜在PDE4抑制剂的设计、合成及生物学评价
Bioorg Med Chem Lett. 2015 Oct 15;25(20):4610-4. doi: 10.1016/j.bmcl.2015.08.043. Epub 2015 Aug 21.
8
Development of highly potent phosphodiesterase 4 inhibitors with anti-neuroinflammation potential: Design, synthesis, and structure-activity relationship study of catecholamides bearing aromatic rings.具有抗神经炎症潜力的高效磷酸二酯酶 4 抑制剂的开发:含芳环儿茶酚胺的设计、合成及构效关系研究。
Eur J Med Chem. 2016 Nov 29;124:372-379. doi: 10.1016/j.ejmech.2016.08.052. Epub 2016 Aug 24.
9
Tetrahydroquinoline and tetrahydroisoquinoline derivatives as potential selective PDE4B inhibitors.作为潜在选择性磷酸二酯酶4B(PDE4B)抑制剂的四氢喹啉和四氢异喹啉衍生物
Bioorg Med Chem Lett. 2018 Oct 15;28(19):3271-3275. doi: 10.1016/j.bmcl.2018.04.068. Epub 2018 May 3.
10
Discovery of oral and inhaled PDE4 inhibitors.口服和吸入型 PDE4 抑制剂的发现。
Bioorg Med Chem Lett. 2013 Oct 15;23(20):5528-32. doi: 10.1016/j.bmcl.2013.08.056. Epub 2013 Aug 21.

引用本文的文献

1
Phosphodiesterase 4B (PDE4B) inhibitors and their applications in recent years (2014 to early 2025).磷酸二酯酶4B(PDE4B)抑制剂及其近年来(2014年至2025年初)的应用。
Mol Divers. 2025 Jun 14. doi: 10.1007/s11030-025-11242-2.
2
PDE4 Inhibitors: Profiling Hits through the Multitude of Structural Classes.PDE4 抑制剂:通过多种结构类别对命中化合物进行剖析。
Int J Mol Sci. 2023 Jul 15;24(14):11518. doi: 10.3390/ijms241411518.